Introduction
There are now nine effective antiviral drugs generally available and their numbers are rapidly increasing. The number of different drug combinations is rising even more rapidly. For example, with only the nine drugs there are 36 two drug and 84 three drug combinations available. With the possibility of switching from one combination to a second combination, patients face the bewildering possibility of over 10 000 different regimens even before a second switch of combination is considered.
Nuffield Department of Medicine, Level It is tempting to assume that CD4 counts will be a good marker of the degree of disease progression while the level of qRNA will be associated with the disease activity and therefore future disease progression.
qRNA has also been used to monitor short term changes in viral load following drug treatment. Zidovudine reduces plasma viral load RNA by about 0.3 log units and two drug combinations of reverse transcriptase inhibitors reduce viral load by up to 1.8 log units. However, the largest changes have been seen in triple therapy regimens which include HIV protease inhibitors. These combinations reduce qRNA by about 2.0 log units and in some cases qRNA falls to below the "limit of detection", which ranges from 10 000 copies (4.0 log units) to 20 copies (1.3 log units), according to the assay. The present enthusiasm for protease inhibitors depends much on the dramatic effect that these drugs have on the viral load. 
